Karen Deane
About Karen Deane
Karen Deane serves as the Senior Director of Clinical Operations at CytomX Therapeutics, having previously held various clinical operations roles at G1 Therapeutics and TARGET PharmaSolutions. With a career spanning over 15 years in clinical operations and research, she has developed extensive expertise in the field.
Work at CytomX Therapeutics
Karen Deane currently serves as the Senior Director of Clinical Operations at CytomX Therapeutics. She has held this position since 2023, contributing to the company's clinical development initiatives. Her role involves overseeing clinical operations, ensuring compliance with regulatory standards, and managing clinical trial processes.
Previous Experience at G1 Therapeutics, Inc.
Before joining CytomX Therapeutics, Karen Deane worked at G1 Therapeutics, Inc. as a Senior Manager of Clinical Operations from 2021 to 2023. During her tenure, she was responsible for managing clinical trials and operational strategies to support the company's drug development programs.
Career at TARGET PharmaSolutions
Karen Deane has held multiple positions at TARGET PharmaSolutions. She served as Associate Director of Clinical Operations from 2016 to 2017 and later as Director of Clinical Operations from 2017 to 2019. In these roles, she focused on enhancing clinical trial efficiency and operational excellence.
Education and Expertise
Karen Deane earned her Bachelor of Arts degree from North Carolina State University, where she studied Psychology, Sociology, and Spanish from 2002 to 2006. Her educational background supports her expertise in clinical operations and management within the pharmaceutical industry.
Professional Background
Karen Deane has a diverse professional background in clinical operations, having worked at various organizations including PPD and Quintiles. Her experience spans roles such as Clinical Team Manager, Regulatory Start Up Lead, and Clinical Compliance Consultant, contributing to her extensive knowledge in the field.